TGFB1 and breast carcinoma: On the other hand, TGF-β-mediated activation of EMT increased the stemness and tumorigenic activities of basal-type breast carcinoma cells through loss of fructose-1, 6-biphosphatase (FBP1) and the consequent activation of pyruvate kinase M2 [46].